Vicuron Pharmaceuticals Inc.

Naicons S.c.a.r.l.

Marco Cavaleri

Daniela Jabes

Giorgio Mosconi

Martin Stogniew

Adriano Malabarba

Timothy Henkel

Richard J White

Romeo Ciabatti

Francesco Parenti

Gianpaolo Candiani

Gabriela Romano

Use of the compound of formula (I) and the pharmaceutically acceptable addition salts thereof for the manufacture of a medicament for topical treatment or 5 prevention of acne formula (I) wherein: R represents methoxymethyl, R1 represents methyl, Rz represents methyl, Y represents the group formula (II) The compound of formula (I) and the pharmaceutically acid addition salts thereof show selective activity againstand are suitable for use in a method of treatment or prevention of acne. 

[object Object]

The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.

Stable pharmaceutical compositions of dalbavancin and methods of administration

Methods of administering dalbavancin for treatment of bacterial infections

The present invention relates to a pharmaceutical composition for intravenous administration that contains ramoplanin or a member of the ramoplanin family.

Injectable formulations containing ramoplanin

Growing community of inventors

Saronno, Italy

Marco Cavaleri